In cardiomyocytes, it may be transcriptionally induced by ATF4, overall driving progressive cardiac fibrosis in diseases such as arrhythmogenic [66] and diabetic [67] cardiomyopathies. This evidence concerns the gene ATF4 and cardiomyopathy.